C07C 243/28
To hydrogen atoms or to carbon atoms of a saturated carbon skeleton
Official title: to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
C07C243/28 (To hydrogen atoms or to carbon atoms of a saturated carbon skeleton) appears on 143 US grants and 117 published applications in this corpus.
Search patents in C07C- Granted patents
- 143
- Published applications
- 117
- Assignees
- 118
- Inventors
- 365
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 5 |
| 2003 | 3 | 4 |
| 2004 | 1 | 6 |
| 2005 | 3 | 5 |
| 2006 | 6 | 2 |
| 2007 | 2 | 4 |
| 2008 | 5 | 3 |
| 2009 | 1 | 6 |
| 2010 | 3 | 2 |
| 2011 | 0 | 1 |
| 2012 | 3 | 6 |
| 2013 | 4 | 7 |
| 2014 | 5 | 2 |
| 2015 | 6 | 5 |
| 2016 | 2 | 6 |
| 2017 | 6 | 8 |
| 2018 | 3 | 6 |
| 2019 | 8 | 6 |
| 2020 | 5 | 3 |
| 2021 | 3 | 8 |
| 2022 | 2 | 6 |
| 2023 | 5 | 7 |
| 2024 | 3 | 2 |
| 2025 | 4 | 4 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Precursor compounds of ester compounds16 Jun 2026US 12,655,092 B2University of Guelph
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Acyclic lipids and methods of use thereof10 Feb 2026US 12,545,636 B2ReNAgade Therapeutics Management Inc.
- L-DOPA and/or DOPA decarboxylse inhibitors conjugated to sugar for the treatment of dopamine-responsive disorders27 Jan 2026US 12,533,417 B2B. G. Negev Technologies and Applications Ltd., At Ben-Gurion University
- HIV inhibitor compounds25 Nov 2025US 12,479,853 B2Gilead Sciences, Inc.
- Hiv inhibitor compounds14 May 2026US 2026/0132139 A1Gilead Sciences, Inc.
- (2,4-dichlorophenoxy)acetic acid analogs12 Feb 2026US 2026/0042731 A1Corteva Agriscience LLC
- Perovskite precursor solution, perovskite thin film, perovskite cell and electrical apparatus8 Jan 2026US 2026/0008795 A1Contemporary Amperex Technology Co., Limited
- Ionizable cationic lipids for lipid nanoparticles30 Oct 2025US 2025/0332112 A1Genevant Sciences GmbH
- Antiozonant and associated rubber composition and rubber article12 Jun 2025US 2025/0188252 A1The Goodyear Tire & Rubber Company
Most cited
By later US patents
- Neprilysin inhibitors67US 8,449,890 B2Theravance, Inc. · 2013
- Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments58US 6,521,431 B1Access Pharmaceuticals, Inc. · 2003
- Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines56US 5,424,333 ARohm and Haas Company · 1995
- Neprilysin inhibitors56US 8,691,868 B2Theravance, Inc. · 2014
- Nitric oxide donor neprilysin inhibitors53US 9,045,443 B2Theravance Biopharma R&D IP, LLC · 2015